Halozyme Therapeutics (HALO) Appoints Interim CFO Amid Growth Plans

On: March 29, 2026, 3:48 pm EDT

URL has been copied successfully!

Share this story:

Previous Post:Pan American Silver Corp. (PAAS) Plans $1.9B Investment to Enable The Largest Silver Mine

Next Post:Super Micro Computer Inc. (SMCI) Reputation and Operations on the Line: Barclays Warns